Back to today’s briefing

Story perspectives

Biomarkup: How Profit Distorts Medical Measures

3/4/2025

30 3

Summary

Story summary

Ken Mandl, director at Boston Children’s Hospital, introduced the term “biomarkup” to highlight the troubling ways commercial interests can distort medical measures for profit. This insight emerged from a conversation with a pharmaceutical company and a diabetes social network, prompting Mandl to ponder the potential impact of artificial intelligence on health metrics.

1 of 1

Story summary

Ken Mandl, director at Boston Children’s Hospital, introduced the term “biomarkup” to highlight the troubling ways commercial interests can distort medical measures for profit. This insight emerged from a conversation with a pharmaceutical company and a diabetes social network, prompting Mandl to ponder the potential impact of artificial intelligence on health metrics.